Biotika a.s. Statistics
Total Valuation
Biotika a.s. has a market cap or net worth of EUR 6.30 million. The enterprise value is 4.12 million.
Market Cap | 6.30M |
Enterprise Value | 4.12M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
Biotika a.s. has 700,000 shares outstanding.
Current Share Class | 564,936 |
Shares Outstanding | 700,000 |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 0.04% |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.55 |
PB Ratio | 0.25 |
P/TBV Ratio | 0.25 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -3.30 |
EV / Sales | 0.36 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -2.36 |
Financial Position
The company has a current ratio of 3.63
Current Ratio | 3.63 |
Quick Ratio | 1.15 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -4.84% and return on invested capital (ROIC) is -4.26%.
Return on Equity (ROE) | -4.84% |
Return on Assets (ROA) | -3.76% |
Return on Invested Capital (ROIC) | -4.26% |
Return on Capital Employed (ROCE) | -6.79% |
Revenue Per Employee | 58,351 |
Profits Per Employee | -6,345 |
Employee Count | 197 |
Asset Turnover | 0.39 |
Inventory Turnover | 2.17 |
Taxes
Income Tax | -140,870 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.00% in the last 52 weeks. The beta is -0.01, so Biotika a.s.'s price volatility has been lower than the market average.
Beta (5Y) | -0.01 |
52-Week Price Change | -55.00% |
50-Day Moving Average | 17.06 |
200-Day Moving Average | 25.49 |
Relative Strength Index (RSI) | 34.62 |
Average Volume (20 Days) | 32 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biotika a.s. had revenue of EUR 11.50 million and -1.25 million in losses. Loss per share was -1.79.
Revenue | 11.50M |
Gross Profit | -772,030 |
Operating Income | -1.76M |
Pretax Income | -1.39M |
Net Income | -1.25M |
EBITDA | -436,486 |
EBIT | -1.76M |
Loss Per Share | -1.79 |
Balance Sheet
The company has 2.18 million in cash and n/a in debt, giving a net cash position of 2.18 million or 3.11 per share.
Cash & Cash Equivalents | 2.18M |
Total Debt | n/a |
Net Cash | 2.18M |
Net Cash Per Share | 3.11 |
Equity (Book Value) | 25.23M |
Book Value Per Share | 36.04 |
Working Capital | 6.99M |
Cash Flow
In the last 12 months, operating cash flow was -779,425 and capital expenditures -969,683, giving a free cash flow of -1.75 million.
Operating Cash Flow | -779,425 |
Capital Expenditures | -969,683 |
Free Cash Flow | -1.75M |
FCF Per Share | -2.50 |
Margins
Gross margin is -6.72%, with operating and profit margins of -15.29% and -10.87%.
Gross Margin | -6.72% |
Operating Margin | -15.29% |
Pretax Margin | -12.10% |
Profit Margin | -10.87% |
EBITDA Margin | -3.80% |
EBIT Margin | -15.29% |
FCF Margin | n/a |
Dividends & Yields
Biotika a.s. does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -19.84% |
FCF Yield | -27.76% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Biotika a.s. has an Altman Z-Score of 4.34 and a Piotroski F-Score of 2.
Altman Z-Score | 4.34 |
Piotroski F-Score | 2 |